Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment
NCT03080181
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Cushing Disease
Interventions
DRUG:
Pasireotide 0.6 MG/ML
Sponsor
University of Palermo